• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Ischemic Stroke Surgery Market Trends

    ID: MRFR/HC/9493-CR
    136 Pages
    Rahul Gotadki
    October 2022

    Ischemic Stroke Surgery Market Research Report Information by Type of Surgery (Thrombectomy, Revascularization Surgery, Carotid Endarterectomy and Angioplasty), by Product Type (Catheter, Aspiration System, Guidewire, Microcatheter and Others), by End User (Hospitals and Clinics, Ambulatory Surgical Centers and Others) Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Ischemic Stroke Surgery Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Trends

    Key Emerging Trends in the Ischemic Stroke Surgery Market

    The Ischemic Stroke Surgery market is witnessing dynamic trends that shape the landscape of stroke interventions and contribute to the ongoing evolution of surgical approaches. These trends reflect advancements in technology, changes in patient preferences, and innovations in medical practices. Let's delve into some key trends influencing the Ischemic Stroke Surgery market. Rise of Endovascular Procedures: Endovascular interventions, such as thrombectomy, have gained prominence in ischemic stroke surgery. The trend towards endovascular procedures is driven by their minimally invasive nature, reduced recovery times, and improved outcomes. This shift represents a departure from traditional surgical methods and a growing reliance on catheter-based techniques to address ischemic strokes. Integration of Robotics and Navigation Systems: The use of robotics and navigation systems in ischemic stroke surgery is a notable trend contributing to precision and efficiency. Robotic-assisted surgeries allow for enhanced control and accuracy during procedures, reducing the risk of complications. The integration of navigation systems aids surgeons in real-time mapping of the vascular system, guiding their interventions with increased accuracy. Advancements in Imaging Technologies: Imaging technologies play a pivotal role in ischemic stroke surgery, aiding in diagnosis and guiding surgical interventions. The market is witnessing a trend towards advanced imaging modalities, such as 3D imaging, perfusion imaging, and artificial intelligence (AI)-powered imaging analytics. These technologies provide detailed insights into vascular structures, enabling more informed decision-making during surgery. Personalized Medicine and Biomarker Research: The trend towards personalized medicine is gaining traction in ischemic stroke surgery. Biomarker research and genetic profiling contribute to tailoring surgical interventions based on individual patient characteristics. This personalized approach aims to optimize treatment strategies, improve patient outcomes, and minimize adverse effects, reflecting a shift towards precision medicine in stroke care. Telemedicine and Remote Monitoring: Telemedicine has become an integral part of healthcare delivery, including stroke management. The trend towards telemedicine in ischemic stroke surgery involves remote consultations, preoperative assessments, and postoperative follow-ups. Additionally, remote monitoring solutions enable healthcare providers to track patient recovery and intervene promptly if any complications arise. Focus on Neuroprotective Strategies: Neuroprotective strategies are emerging as a key trend in ischemic stroke surgery. Efforts are directed towards minimizing neuronal damage during and after surgery. Neuroprotective agents and techniques aim to preserve brain function, reduce inflammation, and enhance overall neurological recovery. This trend underscores a holistic approach to ischemic stroke care beyond the surgical intervention itself. Collaboration and Multidisciplinary Care: Collaborative and multidisciplinary care models are increasingly emphasized in ischemic stroke surgery. The trend involves close collaboration between neurosurgeons, interventional radiologists, neurologists, and rehabilitation specialists. This approach ensures comprehensive care throughout the patient's journey, from diagnosis and surgery to postoperative rehabilitation. Patient-Centric Care and Shared Decision-Making: Patient-centric care is a growing trend in ischemic stroke surgery, emphasizing shared decision-making between healthcare providers and patients. Informed consent, patient education, and involvement in treatment decisions empower individuals undergoing surgery. This trend aligns with the broader shift towards patient-centered healthcare delivery. Global Initiatives for Stroke Prevention and Education: Initiatives aimed at stroke prevention and education are influencing trends in ischemic stroke surgery. Global awareness campaigns, community outreach programs, and educational efforts contribute to early detection, timely intervention, and improved outcomes. These initiatives emphasize the importance of preventive measures and prompt medical attention in reducing the burden of ischemic strokes. Regulatory and Reimbursement Landscape: The evolving regulatory and reimbursement landscape is a trend influencing ischemic stroke surgery. Changes in healthcare policies, insurance coverage, and reimbursement mechanisms impact the accessibility and affordability of surgical interventions. Adapting to these regulatory trends becomes crucial for healthcare providers and manufacturers in the ischemic stroke surgery market. The Ischemic Stroke Surgery market is characterized by dynamic trends that reflect advancements in technology, a shift towards personalized medicine, and a focus on collaborative and patient-centric care models. These trends collectively contribute to the ongoing refinement of surgical approaches, improving patient outcomes, and shaping the future of ischemic stroke interventions. As the field continues to evolve, staying attuned to these trends will be essential for healthcare professionals, researchers, and stakeholders in the ischemic stroke surgery ecosystem.

    Market Summary

    As per Market Research Future Analysis, the Global Ischemic Stroke Surgery Market was valued at USD 3.84 Billion in 2023 and is projected to reach USD 6.77 Billion by 2032, growing at a CAGR of 6.52% from 2024 to 2032. The market is driven by increasing physical inactivity, the launch of advanced products, and a rising demand for minimally invasive procedures. However, challenges such as a lack of medical facilities in developing countries and a shortage of skilled professionals may hinder growth. The COVID-19 pandemic moderately disrupted production and revenue in 2020, but recovery was noted in 2021 as supply chains were restored.

    Key Market Trends & Highlights

    Key trends influencing the ischemic stroke surgery market include technological advancements and demographic shifts.

    • Market Size in 2023: USD 3.84 Billion
    • Projected Market Size by 2032: USD 6.77 Billion
    • CAGR from 2024 to 2032: 6.52%
    • Major Growth Drivers: Increase in sedentary lifestyles and demand for minimally invasive procedures

    Market Size & Forecast

    2023 Market Size USD 3.84 Billion
    2024 Projected Market Size USD 4.08 Billion
    2032 Projected Market Size USD 6.77 Billion
    CAGR (2024-2032) 6.52%

    Major Players

    Stryker (US), Medtronic Plc (Ireland), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Penumbra, Inc. (US), Abbott Laboratories (US), Koninklijke Philips N.V. (Netherlands), Imperative Care (US), Phenox GmbH (Germany)

    Market Trends

    The Global Ischemic Stroke Surgery Market is poised for growth as advancements in surgical techniques and technologies enhance patient outcomes and recovery times.

    U.S. National Institutes of Health (NIH)

    Ischemic Stroke Surgery Market Market Drivers

    Aging Population

    The aging global population is a critical driver of the Global Ischemic Stroke Surgery Market Industry. As individuals age, the risk of ischemic stroke increases significantly due to factors such as hypertension, diabetes, and other comorbidities. This demographic shift necessitates a robust healthcare response, particularly in surgical interventions for stroke management. With a larger segment of the population requiring surgical treatment, the market is poised for growth. The projected increase in market size from 4.08 USD Billion in 2024 to 8.18 USD Billion by 2035 underscores the urgency of addressing the needs of this aging demographic.

    Market Growth Trends

    Growing Awareness and Education

    There is a notable increase in awareness and education regarding stroke symptoms and the importance of timely intervention, which is positively impacting the Global Ischemic Stroke Surgery Market Industry. Public health campaigns and educational programs are encouraging individuals to seek immediate medical attention when experiencing stroke symptoms. This heightened awareness leads to earlier diagnosis and treatment, which is crucial for successful surgical outcomes. As more patients become informed about their options, the demand for ischemic stroke surgeries is likely to rise, contributing to the overall growth of the market.

    Increasing Healthcare Expenditure

    The rise in global healthcare expenditure is a significant factor influencing the Global Ischemic Stroke Surgery Market Industry. Governments and private sectors are investing more in healthcare infrastructure, leading to enhanced access to surgical interventions for ischemic stroke patients. This increased funding allows for the procurement of advanced surgical equipment and training for healthcare professionals. As healthcare systems prioritize stroke management, the market is expected to benefit from improved facilities and resources. This trend aligns with the projected growth of the market, reaching 4.08 USD Billion in 2024 and continuing to expand towards 8.18 USD Billion by 2035.

    Rising Incidence of Ischemic Stroke

    The increasing prevalence of ischemic stroke globally is a primary driver for the Global Ischemic Stroke Surgery Market Industry. According to health statistics, ischemic strokes account for approximately 87 percent of all strokes, leading to a growing demand for surgical interventions. As the global population ages, the incidence of ischemic strokes is projected to rise, necessitating advancements in surgical techniques and technologies. This trend is expected to contribute significantly to the market's growth, with the industry projected to reach 4.08 USD Billion in 2024 and potentially 8.18 USD Billion by 2035, reflecting a compound annual growth rate of 6.53% from 2025 to 2035.

    Technological Advancements in Surgical Procedures

    Innovations in surgical techniques and technologies are transforming the Global Ischemic Stroke Surgery Market Industry. Minimally invasive procedures, such as endovascular thrombectomy, have shown promising results in improving patient outcomes. These advancements not only enhance the efficacy of surgeries but also reduce recovery times, thereby increasing patient throughput. The integration of robotic-assisted surgery and advanced imaging techniques further supports the precision of interventions. As hospitals and surgical centers adopt these technologies, the market is likely to expand, driven by the demand for improved surgical outcomes and patient satisfaction.

    Market Segment Insights

    Regional Insights

    Key Companies in the Ischemic Stroke Surgery Market market include

    Industry Developments

      • In February 2022, Imperative Care launched the Zoom POD for stroke therapy. The Zoom POD is the world's first and only sterile field clot filtration device, allowing for speedier clot collection during essential mechanical thrombectomy treatments for patients suffering from ischemic stroke.
      • In February 2022, Johnson & Johnson Services, Inc. launched EMBOGUAR, a next-generation balloon guide catheter for use in endovascular therapies, notably those for patients suffering from acute ischemic stroke.
      • In October 2021, Phenox GmbH launched the pRESET 6-50 mechanical thrombectomy device to broaden its technological range for acute ischemic stroke across the globe.
      • In September 2021, Abbott acquired Walk Vascular, LLC (US), a medical device company with a minimally invasive mechanical aspiration system designed to remove peripheral blood clots. This acquisition will help to expand the company's peripheral vascular offerings.
      • In February 2021, Phenox GmbH expands with the creation of a new office in the UK to increase its presence in important markets around Europe.

    Future Outlook

    Ischemic Stroke Surgery Market Future Outlook

    The Ischemic Stroke Surgery Market is projected to grow at a 6.53% CAGR from 2024 to 2035, driven by advancements in surgical techniques, increasing prevalence of ischemic strokes, and enhanced healthcare infrastructure.

    New opportunities lie in:

    • Invest in AI-driven surgical tools to improve precision and outcomes.
    • Develop minimally invasive techniques to reduce recovery times and costs.
    • Expand telemedicine services for pre- and post-operative care to enhance patient access.

    By 2035, the Ischemic Stroke Surgery Market is expected to be robust, reflecting significant advancements and increased accessibility.

    Market Segmentation

    Report Overview

    Global Ischemic Stroke Surgery Market, by Region
    • {"North America"=>["US", "Canada"]}
    • {"Europe"=>["Germany", "France", "UK", "Italy", "Spain", "Rest of Europe"]}
    • {"Asia-Pacific"=>["China", "India", "Japan", "Australia"]}
    • Rest of the World
    Global Ischemic Stroke Surgery Market, by End User
    • Hospitals And Clinics
    • Ambulatory Surgical Centers
    • Others
    Global Ischemic Stroke Surgery Market, by Product Type
    • Catheter
    • Aspiration System
    • Guidewire
    • Microcatheter
    • Others
    Global Ischemic Stroke Surgery Market, by Type of Surgery
    • Thrombectomy
    • Revascularization Surgery
    • Carotid Endarterectomy
    • Angioplasty
    • Others

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 3.84 (USD Billion)
    Market Size 2024 4.08 (USD Billion)
    Market Size 2032 6.77 (USD Billion)
    Compound Annual Growth Rate (CAGR) 6.52 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, Rest of the World
      Key Vendors   Stryker (US), Medtronic PLC (Ireland), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Penumbra, Inc. (US), Abbott Laboratories (US), Koninklijke Philips N.V. (Netherlands), Imperative Care (US), Abbott Laboratories (US), and Phenox GmbH (Germany)
      Key Market Opportunities  R&D activities and investments
      Key Market Drivers  Rise in physical inactivity and sedentary lifestyles • Adoption and launch of technologically advanced products Rising demand for minimally invasive procedures

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    How Big is the Ischemic Stroke Surgery market?

    The Ischemic Stroke Surgery Market is anticipated to reach USD 6.77 billion by 2035 and register a CAGR of 6.52% during the forecast period of 2024 to 2032.

    Who are the key competitors in the market of Ischemic Stroke Surgery?

    Stryker (US), Medtronic PLC (Ireland), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Penumbra, Inc. (US), Abbott Laboratories (US), Koninklijke Philips N.V. (Netherlands), Imperative Care (US), Abbott Laboratories (US), and Phenox GmbH (Germany) are the key players in the market of Ischemic Stroke Surgery

    Which region is predicted to have the largest market share of Ischemic Stroke Surgery

    North America is predicted to lead the market of Ischemic Stroke Surgery

    What are the key factors driving the market of Ischemic Stroke Surgery?

    Rise in physical inactivity and sedentary lifestyles and Adoption and launch of technologically advanced products are driving the market growth

    Which factors may act as market deterrents Ischemic Stroke Surgery?

    Lack of medical facilities and Shortage of skilled professionals are the market deterrents.

    1. Table of Contents
    2. Executive Summary
      1. OVERVIEW
    3. Market Introduction
      1. DEFINITION
      2. Scope of the Study
      3. RESEARCH OBJECTIVE
      4. MARKET STRUCTURE
      5. ASSUMPTIONS & LIMITATIONS
    4. Research Methodology
      1. DATA MINING
      2. SECONDARY RESEARCH
      3. PRIMARY RESEARCH
      4. BREAKDOWN OF PRIMARY RESPONDENTS
      5. FORECASTING TECHNIQUES
      6. Research Methodology FOR MARKET SIZE ESTIMATION
        1. Bottom-up Approach
        2. TOP-DOWN APPROACH
      7. DATA TRIANGULATION
      8. VALIDATION
    5. MARKET DYNAMICS
      1. OVERVIEW
      2. DRIVERS
        1. RISE IN PHYSICAL INACTIVITY AND SEDENTARY LIFESTYLES
        2. ADOPTION AND LAUNCH OF TECHNOLOGICALLY ADVANCED PRODUCTS
        3. RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
      3. RESTRAINTS
        1. LACK OF MEDICAL FACILITIES
        2. SHORTAGE OF SKILLED PROFESSIONALS
      4. OPPORTUNITIES
        1. R&D ACTIVITIES AND INVESTMENTS
    6. MARKET FACTOR ANALYSIS
      1. VALUE CHAIN ANALYSIS
        1. R&D
        2. MANUFACTURING
        3. DISTRIBUTION AND SALES
        4. POST-SALES MONITORING
      2. PORTER’S FIVE FORCES MODEL
        1. THREAT OF NEW ENTRANTS
        2. BARGAINING POWER OF SUPPLIERS
        3. THREAT OF SUBSTITUTES
        4. BARGAINING POWER OF BUYERS
        5. INTENSITY OF RIVALRY
      3. IMPACT OF COVID-19 ON THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
        1. IMPACT ON SUPPLY CHAIN
        2. IMPACT ON PRODUCTION
        3. IMPACT ON DEMAND
      4. EPIDEMIOLOGY ANALYSIS
        1. INCIDENCE & PREVALENCE
        2. NUMBER OF PROCEDURES FOR THROMBECTOMY
      5. REGULATORY ANALYSIS/HEALTHCARE SYSTEM
    7. GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY
      1. OVERVIEW
      2. THROMBECTOMY
      3. REVASCULARIZATION SURGERY
      4. CAROTID ENDARTERECTOMY
      5. ANGIOPLASTY
      6. OTHERS
    8. GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE
      1. OVERVIEW
      2. CATHETER
      3. ASPIRATION SYSTEM
      4. GUIDEWIRE
      5. MICROCATHETER
      6. OTHERS
    9. GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY END USER
      1. OVERVIEW
      2. HOSPITALS AND CLINICS
      3. AMBUATORY SURGICAL CENTRES
      4. OTHERS
    10. GLOBAL ISCHEMIC STROKE SURGERY MARKET, BY REGION
      1. OVERVIEW
      2. NORTH AMERICA
        1. US
        2. CANADA
      3. EUROPE
        1. GERMANY
        2. UK
        3. FRANCE
        4. ITALY
        5. SPAIN
        6. REST OF EUROPE
      4. ASIA PACIFIC
        1. JAPAN
        2. CHINA
        3. INDIA
        4. AUSTRALIA
        5. SOUTH KOREA
        6. REST OF ASIA PACIFIC
      5. REST OF THE WORLD
        1. MIDDLE EAST
        2. AFRICA
        3. LATIN AMERICA
    11. Competitive Landscape
      1. OVERVIEW
      2. MARKET SHARE ANAYISIS
      3. COMPETITIVE BENCHMARKING
      4. MAJOR GROWTH STRATEGY IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
      5. THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
      6. KEY DEVELOPMENT ANALYSIS
      7. KEY DEVELOPMENTS & GROWTH STRATEGIES
        1. MERGER & ACQUISITIONS
        2. AGREEMENT/MARKETING STRATEGIES
      8. FINANCIAL MATRIX
        1. SALES (USD MILLION), 2021
        2. RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021
    12. COMPANY PROFILES
      1. MEDTRONIC PLC
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      2. ABBOTT LABORATORIES
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
      3. BOSTON SCIENTIFIC CORPORATION
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
      4. CORDIS CORPORATION
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
      5. KONINKLIJKE PHILIPS N.V
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      6. STRYKER
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      7. IMPERATIVE CARE
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
      8. JOHNSON & JOHNSON SERVICES, INC.
        1. COMPANY OVERVIEWS
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      9. PENUMBRA, INC.
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      10. PHENOXYHENOX GMBH
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
    13. APPENDIX
      1. REFERENCES
      2. RELATED REPORTS
    14.  
    15. List of Tables and Figures
      1. LIST OF TABLES
      2. TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
      3. TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
      4. TABLE 3 NUMBER OF PROCEDURES FOR THROMBECTOMY, BY REGION (2021)
      5. TABLE 4 NUMBER OF PROCEDURES FOR THROMBECTOMY, BY COUNTRY (2021)
      6. TABLE 5 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      7. TABLE 6 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR THROMBECTOMY, BY REGION, 2018–2035 (USD MILLION)
      8. TABLE 7 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR REVASCULARIZATION SURGERY, BY REGION, 2018–2035 (USD MILLION)
      9. TABLE 8 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR CAROTID ENDARTERECTOMY, BY REGION, 2018–2035 (USD MILLION)
      10. TABLE 9 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR ANGIOPLASTY, BY REGION, 2018–2035 (USD MILLION)
      11. TABLE 10 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS, BY REGION, 2018–2035 (USD MILLION)
      12. TABLE 11 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      13. TABLE 12 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR CATHETER, BY REGION, 2018–2035 (USD MILLION)
      14. TABLE 13 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR ASPIRATION SYSTEM, BY REGION, 2018–2035 (USD MILLION)
      15. TABLE 14 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR GUIDEWIRE, BY REGION, 2018–2035 (USD MILLION)
      16. TABLE 15 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR MICROCATHETER, BY REGION, 2018–2035 (USD MILLION)
      17. TABLE 16 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS, BY REGION, 2018–2035 (USD MILLION)
      18. TABLE 17 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      19. TABLE 18 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2018–2035 (USD MILLION)
      20. TABLE 19 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR AMBULATORY SURGERY CENTRES, BY REGION, 2018–2035 (USD MILLION)
      21. TABLE 20 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, FOR OTHERS BY REGION, 2018–2035 (USD MILLION)
      22. TABLE 21 GLOBAL: ISCHEMIC STROKE SURGERY MARKET, BY REGION, 2018–2035 (USD MILLION)
      23. TABLE 22 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018–2035 (USD MILLION)
      24. TABLE 23 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      25. TABLE 24 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      26. TABLE 25 NORTH AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      27. TABLE 26 US: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      28. TABLE 27 US: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      29. TABLE 28 US: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      30. TABLE 29 CANADA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      31. TABLE 30 CANADA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      32. TABLE 31 CANADA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      33. TABLE 32 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018–2035 (USD MILLION)
      34. TABLE 33 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      35. TABLE 34 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      36. TABLE 35 EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      37. TABLE 36 GERMANY: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      38. TABLE 37 GERMANY: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      39. TABLE 38 GERMANY: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      40. TABLE 39 UK: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      41. TABLE 40 UK: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      42. TABLE 41 UK: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      43. TABLE 42 FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      44. TABLE 43 FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      45. TABLE 44 FRANCE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      46. TABLE 45 ITALY: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      47. TABLE 46 ITALY: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      48. TABLE 47 ITALY: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      49. TABLE 48 SPAIN: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      50. TABLE 49 SPAIN: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      51. TABLE 50 SPAIN: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      52. TABLE 51 REST OF EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      53. TABLE 52 REST OF EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      54. TABLE 53 REST OF EUROPE: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      55. TABLE 54 ASIA PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY COUNTRY, 2018-2035 (USD MILLION)
      56. TABLE 55 ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      57. TABLE 56 ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      58. TABLE 57 ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      59. TABLE 58 JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      60. TABLE 59 JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      61. TABLE 60 JAPAN: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      62. TABLE 61 CHINA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      63. TABLE 62 CHINA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      64. TABLE 63 CHINA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      65. TABLE 64 INDIA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      66. TABLE 65 INDIA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      67. TABLE 66 INDIA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      68. TABLE 67 AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      69. TABLE 68 AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      70. TABLE 69 AUSTRALIA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      71. TABLE 70 SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      72. TABLE 71 SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      73. TABLE 72 SOUTH KOREA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      74. TABLE 73 REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      75. TABLE 74 REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      76. TABLE 75 REST OF ASIA-PACIFIC: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      77. TABLE 76 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY REGION, 2018-2035(USD MILLION)
      78. TABLE 77 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      79. TABLE 78 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      80. TABLE 79 REST OF THE WORLD: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      81. TABLE 80 MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      82. TABLE 81 MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      83. TABLE 82 MIDDLE EAST: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      84. TABLE 83 AFRICA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      85. TABLE 84 AFRICA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      86. TABLE 85 AFRICA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      87. TABLE 86 LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY TYPE OF SURGERY, 2018–2035 (USD MILLION)
      88. TABLE 87 LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY PRODUCT TYPE, 2018–2035 (USD MILLION)
      89. TABLE 88 LATIN AMERICA: ISCHEMIC STROKE SURGERY MARKET, BY END USER, 2018–2035 (USD MILLION)
      90. TABLE 89 MAJOR PLAYERS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
      91. TABLE 90 MOST ACTIVE PLAYERS IN THE GLOBAL ISCHEMIC STROKE SURGERY MARKET
      92. TABLE 91 PRODUCT LAUNCH/PRODUCT APPROVAL
      93. TABLE 92 MERGER & ACQUISITIONS
      94. TABLE 93 AGREEMENT/MARKETING STRATEGIES
      95. TABLE 94 MEDTRONIC PLC: PRODUCTS OFFERED
      96. TABLE 95 ABBOTT LABORATORIES: PRODUCTS OFFERED
      97. TABLE 96 ABBOTT LABORATORIES: KEY DEVELOPMENTS
      98. TABLE 97 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
      99. TABLE 98 CORDIS CORPORATION: PRODUCTS OFFERED
      100. TABLE 99 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED

    Ischemic Stroke Surgery Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027